The Genomics4RD platform is focused on data harmonization from research collaborations across Canada, but its developers are eyeing a future in the clinical market.
The new IQvia E360 Genomics build includes a "privacy-preserving" database system and will soon have analytic tools to support genotype-phenotype research.
New funding will support assay development and lab space to offer test services, and ultimately a test kit using the firm's resistance database.
With the acquisition, Qiagen will integrate N-of-One’s MarkerMine database into its core technology to help customers design new, targeted therapies.
The partners will leverage Singapore’s clinical network to collect a variety of 'omics data from consenting individuals and store the data for local researchers to investigate.
In a recent study, a pair of researchers found that CNAs in cancer driver genes are better prognostic markers than mutations in the same genes.
The center, set to open next year, will establish a national sequencing infrastructure, manage a national genome database, and make the data available for research.
The companies intend to study de-identified, population-scale phenotypic and genotypic data to gain unique insights that may support the broader HCM ecosystem.
The company presented Color Data as a resource for variant classification scientists and hopes it will inspire industry peers to similarly share data.
The two papers published today in Science and Cell have implications for both forensics and genetic research.
The long-running Framingham Heart Study has received a $38 million grant, according to the Boston Globe.
A Stanford University investigation finds that its researchers did not take part in He Jiankui's work to develop gene-edited infants.
Retraction Watch reports that two researchers had both a Science and a Nature paper retracted last week.
In Genome Biology this week: genomic sequencing of milkweed bug, benchmark comparison of single-cell RNA sequencing platforms, and more.